KPV

KPV is a tripeptide representing the C-terminal fragment of alpha-melanocyte stimulating hormone (α-MSH). Despite lacking the melanogenic activity of full-length α-MSH or its N-terminal fragments, KPV retains potent anti-inflammatory properties. This makes it a valuable research tool for studying inflammation without the confounding effects of melanogenesis.

The anti-inflammatory effects of α-MSH were initially attributed to melanocortin receptor activation, but KPV's activity (without significant MC receptor binding) suggests alternative mechanisms for the anti-inflammatory properties of melanocortin peptides.

KPV exerts anti-inflammatory effects through non-melanocortin pathways:

NF-κB Inhibition KPV inhibits the nuclear factor kappa-B (NF-κB) signaling pathway, a master regulator of inflammatory gene expression. This reduces production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6.

Inflammasome Modulation Research indicates KPV may affect NLRP3 inflammasome activation, reducing IL-1β maturation and release. This pathway is important in various inflammatory conditions.

Direct Cellular Entry Unlike receptor-mediated signaling, KPV can enter cells directly due to its small size and amino acid composition. This may allow it to interact with intracellular signaling components directly.

JAK/STAT Pathway Some studies suggest KPV affects Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling, another major inflammatory pathway.